Product portfolio

Donor screening

Blood transfusions and plasma derived therapeutics help to save lives every day

Ensuring access to a sufficient and safe supply of whole blood and plasma products is a challenge1. As a global leader and the single provider for a complete donor screening solution to blood centers and plasma fractionators worldwide*, Roche recognizes this challenge and is committed to keeping the blood and plasma supply safe. To this end, we:

  • Provide the most comprehensive donor screening solution
  • Engage in active surveillance of emerging pathogens 
  • Partner with leaders in the field of blood safety to develop innovative solutions
  • Offer healthcare consulting to optimize each individual laboratory's solution

*Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability. Serology portfolio is not available in USA and Philippines. The CCM variant is not cleared in the US for blood donor screening. For cobas p 312, cobas p 512 and cobas p 612 used in US blood establishments, the IT solution is limited to Data Innovations.

References

  1. World Health Organization (WHO). Blood transfusion safety.  https://www.who.int/health-topics/blood-transfusion-safety#tab=tab_1
Found 0 results in
Filters
...
    ...